SARcode Biosciences' Series A Round

SARcode Biosciences raised a round of funding on December 23, 2009.

SARcode is a private, San Francisco based biotechnology company focused on the development of small molecule LFA-1 antagonists to treat inflammatory diseases. Targets include topical therapies for T-c…

Articles about SARcode Biosciences' Series A Round: